Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Technical Corrections Legislation Doubtful After Rx Bill Passage

This article was originally published in The Gray Sheet

Executive Summary

The resolve of House Republican leaders to avoid re-opening the controversial Medicare law with a technical corrections bill in 2004 will limit DME competitive bidding opponents' options in repealing the provision

You may also be interested in...

United They Stand? Differing Device Platforms Share FDA Oversight Plank

Device advocacy groups credit a maturing industry presence on Capitol Hill, reflected by CEO-level participation, with achieving relevant Medicare reforms and a focus on FDA accountability

Evidence-Based Medicine Chasm: Can CMS, Industry Find Common Ground?

CMS' growing emphasis on evidence-based medicine to inform reimbursement decisions increasingly will lead manufacturers to conduct "high-quality" clinical trials, according to Chief Medical Officer Sean Tunis

DES Rates Sustained, CMS Exerting Price Pressures: Payment Recap

Johnson & Johnson/Cordis' efforts to raise the drug-eluting stent inpatient payment rates fell short in 2003, paving the way for the Cypher manufacturer and imminent competitor Boston Scientific (Taxus) to wage a concerted lobbying campaign this year

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts